medroxyprogesterone acetate has been researched along with Body Weight in 121 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (23.97) | 18.7374 |
| 1990's | 44 (36.36) | 18.2507 |
| 2000's | 30 (24.79) | 29.6817 |
| 2010's | 18 (14.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bekele, T; Ferede, YM; Malik, T; Yeshaw, Y; Zerihun, MF | 1 |
| Chen, M; Edelman, A; Helmerhorst, FM; Lopez, LM; Otterness, C; Trussell, J | 1 |
| Diedrich, JT; Drey, EA; Harper, CC; Sokoloff, A; Steinauer, JE; Upadhyay, UD | 1 |
| Albright, M; Gavagan, T; Rani, S | 1 |
| Cosman, F; Lindsay, R; Nieves, JW; Ruffing, JA; Tendy, S; Yavorek, T; Zion, M | 1 |
| Bateman, LA; Price, TM; Slentz, C; Stanczyk, FZ; Steward, RG | 1 |
| Chen, M; Edelman, A; Helmerhorst, FM; Lopez, LM; Otterness, C; Ramesh, S; Trussell, J | 1 |
| Bonny, AE; Gothard, MD; Lange, HL; Manos, BE; Rogers, LK | 1 |
| Berenson, AB; Rahman, M | 1 |
| Baccarin, MC; Fernandes, AM; Medeiros, T; Morais, S; Pantoja, M | 1 |
| Brito, MB; Ferriani, RA; Quintana, SM; Silva de Sá, MF; Vieira, CS; Yazlle, ME | 1 |
| Beksinska, ME; Farley, TM; Kleinschmidt, I; Milford, C; Smit, JA | 1 |
| Baccarin, MC; Bahamondes, L; Fernandes, AM; Medeiros, T; Morais, SS; Pantoja, M | 1 |
| Juraska, JM; Lowry, NC; Pardon, LP; Yates, MA | 1 |
| Bonny, AE; Cromer, BA; Secic, M | 1 |
| Katsumata, N; Kikuchi, T; Nagasaki, K; Ogawa, Y; Uchiyama, M | 1 |
| Britt, RB; Faisel, AJ; Leblanc, AD; Rianon, NJ; Shahidullah, SM | 1 |
| Bonny, AE; Cromer, B; Secic, M | 1 |
| Chen-Mok, M; Edelman, A; Helmerhorst, FM; Lopez, LM; Trussell, J | 1 |
| Chen, SZ; Zhang, YL | 1 |
| Madden, T; Nault, AM; Peipert, JF; Secura, GM; Zhao, Q | 1 |
| Fraser, IS | 1 |
| Mukherjea, M | 1 |
| Hatcher, RA; Schnare, S | 1 |
| Luyando, H; Rustrian, A | 1 |
| Ojo, OA; Wien, EM | 1 |
| Cai, RF; Cui, YG; Di, FS; Jia, Y; Ma, DZ; Sha, JH; Tong, JS; Wang, XH | 1 |
| Allum, AR; de Jong, SA; Jones, SD; Manning, PJ; Sutherland, WH | 1 |
| HECHT-LUCARI, G; MOLA, T | 1 |
| Anthony, MS; Clarkson, TB; Rankin, SE; Shadoan, MK; Wagner, JD | 1 |
| Akhter, M; Khan, MR; Mia, AR; Shampa, SS; Siddiqui, NI | 1 |
| Bode, FR; Jain, J; Jakimiuk, AJ; Kaunitz, AM; Ross, D | 1 |
| Knopp, RH; Leboeuf, RC; Rosenfeld, ME; Shultz, JM; Zhu, XD | 1 |
| Clark, MK; Dillon, JS; Nichols, S; Sowers, M | 1 |
| Fox, JL; Koudy Williams, J; Suparto, IH; Vinten-Johansen, J | 1 |
| Banhidy, F; Komjati, K; Mersich, T; Sandor, P; Szekacs, B; Szelke, E; Varbiro, S | 1 |
| Blackman, MR; Harman, SM; Münzer, T; Pabst, KM; Rosen, CJ; Sorkin, JD; St Clair, C | 1 |
| Shittu, O; Sule, S | 1 |
| Matthews, DE; Sites, CK; Toth, MJ | 1 |
| Kaunitz, AM; McClung, MR; Miller, PD; Rice, VM; Ross, D | 1 |
| Amory, JK; Anawalt, BD; Bremner, WJ; Brockenbrough, AT; Irwig, MS; Matsumoto, AM; Page, ST | 1 |
| Eren, S; Kutlu, T; Pekin, O; Tugrul, S; Uslu, H; Yildirim, G | 1 |
| Demircan, S; Kizilkaya, K; Köseoğlu, K; Odabasi, AR; Onur, E; Yüksel, H | 1 |
| Anthony, MS; Kavanagh, K; Shadoan, MK; Wagner, JD; Zhang, L | 1 |
| Bakry, S; Fadiel, A; Mahmoud, MS; Merhi, ZO; Naftolin, F; Scalise, TJ | 1 |
| Biswas, R; Mukherjea, M; Mukherjee, P | 1 |
| Dahlberg, K | 1 |
| Itoh, I; Kitamura, M; Saito, T; Tominaga, T | 1 |
| Fotherby, K; Koetsawang, S; Mangalam, M; Nukulkarn, P; Shrimanker, K; Towobola, K | 1 |
| Soler, NG; Wortsman, J | 1 |
| Fajumi, JO | 1 |
| Jimenez, J; Ochoa, M; Portales, P; Soler, MP | 1 |
| Ayeni, O; Chalapati, S; Dusitsin, N; Gellen, JJ; Gray, R; Koetsawang, S; Pinol, A; Saibiang, S; Sas, M; Tankeyoon, M | 1 |
| Boni, L; Hendrikx, A; Kieckens, L | 1 |
| Brown, R; Hensley, MJ; Ingram, RH; Saunders, NA; Scharf, SM; Strohl, KP | 1 |
| Burroni, P; Camaggi, CM; Cricca, A; Fruet, F; Gaggi, R; Murari-Colalongo, G; Pannuti, F | 1 |
| Di Marco, AR; Fruet, F; Martoni, A; Pannuti, F; Strocchi, E | 1 |
| Adler, D; Brzezinski, A; Reubinoff, BE; Rojansky, N; Schenker, JG; Stein, P; Wurtman, J | 1 |
| Cosman, F; Lindsay, R; Nieves, J; Shen, V | 1 |
| Hales, HA; Hatasaka, HH; Jones, KP; Mainwaring, R; Peterson, CM; Poulson, AM; Stevenson, K | 1 |
| Chen, JK; Chen, SF; Fang, KJ; Ge, JL; Ge, RS; He, ML; Luo, SY; Sang, GW; Shao, QX; Song, S | 1 |
| Gua, C; Kriengsinyot, R; Leepipatpaiboon, S; Reinprayoon, D; Virutamasen, P; Wangsuphachart, S | 1 |
| Epstein, S; Isserow, JA; Liu, CC; Mann, GN; Romero, DF; Rucinski, B | 1 |
| Baccino, FM; Costelli, P; Tessitore, L | 1 |
| Ashizawa, T; Gomi, K; Ishida, H; Okabe, M | 1 |
| Boschitsch, E; Egarter, C; Geurts, P; Huber, J; Speiser, P | 1 |
| Aaronson, NK; Blijham, GH; Cobben, EG; Demedts, M; Drenth, BM; Erdkamp, FL; Hillen, HF; Muller, MJ; Schoon, EJ; Schouten, HC; Simons, JP; Smeets, JB; ten Velde, GP; Vansteenkiste, JF; Wouters, EF | 1 |
| Cornish, J; Cundy, T; Farquhar, CM; Reid, IR | 1 |
| Garceau, RJ; Jiang, S; Lei, ZW; Vander Meulen, TC; Wang, WL; Wu, SC; Yang, QZ | 1 |
| Cuong, DT; My Huong, NT | 1 |
| Chen, SJ; Chen, YF; Durand, J; Levine, RL; Oparil, S | 1 |
| Espeland, MA; Fineberg, SE; Greendale, GA; James, MK; Kritz-Silverstein, D; Stefanick, ML; Waclawiw, MA | 1 |
| Anthony, MS; Brosnihan, KB; Ferrario, CM; Heise, C; Li, P; Weddle, D | 1 |
| Battistutta, D; Coglan, MJ; DeVoss, KN; Khoo, SK; Wright, GR | 1 |
| Hellerstedt, WL; Story, M | 1 |
| Menozzi, G | 1 |
| Gruss, J; Keder, LM; Rulin, MC | 1 |
| Kurebayashi, J; Otsuki, T; Sonoo, H; Yamamoto, S | 1 |
| Bahamondes, L; Diaz, J; Hall, P; Petta, C | 1 |
| Moeloek, N; Soeradi, O; Sri Sukmaniah, S; Suhana, N; Supriatna, J | 1 |
| Barillaro, F; Capri, O; Critelli, C; Galoppi, P; Liu, Y; Perrone, G; Zichella, L | 1 |
| Barratt, MS; Gefter, LR; Risser, JM; Risser, WL | 1 |
| Jaisamrarn, U; Reinprayoon, D; Taneepanichskul, S | 1 |
| Arbogast, K; Archer, DF; Baker, J; Callahan, MM; Chen-Mok, M; Gabelnick, HL; Mauck, CK; Morrison, CS; Pan, Z; Stock, R; Veazey, R | 1 |
| Koga, T; Mitsuyama, S; Nomura, Y; Ogawa, M; Ogawa, N; Ohno, S; Shirouzu, K; Sugimachi, K; Takayama, T; Yamashita, J | 1 |
| Cromie, MA; Hopkins, NK; Rahimy, MH; Tong, DM | 1 |
| Heinbach, RA; Pelkman, CL; Rolls, BJ | 1 |
| Danli, S; Guowei, S; Qingxiang, S | 1 |
| Chow, M; Heinbach, RA; Pelkman, CL; Rolls, BJ | 1 |
| Garceau, RJ; Kaunitz, AM; Wajszczuk, CJ | 1 |
| Hatfield, PG; Stellflug, JN; Walker, JW; Wulster-Radcliffe, MC | 1 |
| Bahamondes, L; Castro, S; Perrotti, M; Petta, C | 1 |
| Cappagli, B; Ciaponi, M; Gambacciani, M; Genazzani, AR | 1 |
| Hirvonen, E; Lobo, RA; Pickar, JH; Walsh, B; Wild, RA | 1 |
| Bäckström, T; Bixo, M; Björn, I; Collberg, P; Nöjd, KS; Nyberg, S; Sundström-Poromaa, I | 1 |
| Duckles, SP; Krause, DN; McNeill, AM; Stanczyk, FZ; Zhang, C | 1 |
| Chambers, HM; Kirkgard, Y; MacLennan, A; MacLennan, AH; O'Neill, S; Wenzel, S | 1 |
| Gray, R; Pardthaisong, T; Yenchit, C | 1 |
| Hussain, SP; Rao, AR | 1 |
| Harada, Y; Horiguchi, T; Kimura, T; Nogimura, H; Sugimura, H; Suzuki, K; Tomii, M; Wada, H | 1 |
| Bauché, F; Jégou, B; Velez de la Calle, JF | 1 |
| Bellantoni, MF; Blackman, MR; Cullins, VE; Engelhardt, SM; Harman, SM | 1 |
| Bologna, A; Dal Magro, L; Dal Pozzo, M; Fiscon, D; Marchesoni, D; Mozzanega, B | 1 |
| Kuno, K | 1 |
| Abdel-Sayed, WS; Darwish, EA; el-Habashy, MA; Haiba, NA; Nayel, SE; Said, SA | 1 |
| de Pauw, M; de Voogt, HJ; Pavone-Macaluso, M; Smith, PH; Suciu, S | 1 |
| Schmidt, NA; Thijssen, JH; Trienekens, PH | 1 |
| Carroad, EG; Easter, MD; Hammock, BD; Helferich, WG; Moody, DE; Shull, LR | 1 |
| Ajmal, F; Benitez, IB; Kazi, A; Kiriwat, O; Koetsawang, S; Omar, K; Pretnar-Darovec, A; Said, S; Srisatayapan, Y; Wynter, HH | 1 |
| Boucque, CV; Buysse, FX; Casteels, M; Cottyn, BG; Fiems, LO | 1 |
| Emory, LE; Meyer, WJ; Smith, ER; Walker, PA | 1 |
| Fujii, M; Hagiwara, K; Nagasawa, H | 1 |
| Miura, S; Murai, H; Yoshida, M | 1 |
| Hurlet, A; Hyjazi, Y; Maes, E; Masure, R; Vekemans, M | 1 |
5 review(s) available for medroxyprogesterone acetate and Body Weight
| Article | Year |
|---|---|
Progestin-only contraceptives: effects on weight.
Topics: Body Composition; Body Weight; Contraceptives, Oral, Hormonal; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Progestins; Weight Gain | 2013 |
Progestin-only contraceptives: effects on weight.
Topics: Adolescent; Adult; Body Composition; Body Weight; Contraceptives, Oral, Hormonal; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Progestins; Prospective Studies; Retrospective Studies; Weight Gain | 2016 |
Progestin-only contraceptives: effects on weight.
Topics: Body Weight; Contraceptives, Oral, Hormonal; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Progestins; Weight Gain | 2011 |
Depot-medroxyprogesterone acetate: an update.
Topics: Abnormalities, Drug-Induced; Anemia, Sickle Cell; Animals; Arachnoiditis; Body Weight; Bone Density; Contraceptive Agents, Female; Female; Humans; Hypertension; Lactation; Lipoproteins; Liver; Medroxyprogesterone Acetate; Neoplasms | 2008 |
The effects of estradiol valerate plus medroxyprogesterone acetate and conjugated estrogens plus medrogestone on climacteric symptoms and metabolic variables in perimenopausal women.
Topics: Adult; Age Factors; Body Weight; Climacteric; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hemostasis; Humans; Lipid Metabolism; Medrogestone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Postmenopause; Premenopause; Progesterone Congeners | 1996 |
41 trial(s) available for medroxyprogesterone acetate and Body Weight
| Article | Year |
|---|---|
Bone Mineral Density and Weight Changes in Adolescents Randomized to 3 Doses of Depot Medroxyprogesterone Acetate.
Topics: Adolescent; Body Weight; Bone Density; Child; Contraceptive Agents, Female; Dose-Response Relationship, Drug; Female; Humans; Lumbar Vertebrae; Medroxyprogesterone Acetate; Ohio; Prospective Studies; Young Adult | 2017 |
Changes in weight, total fat, percent body fat, and central-to-peripheral fat ratio associated with injectable and oral contraceptive use.
Topics: Adipose Tissue; Adolescent; Adult; Body Weight; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Female; Humans; Medroxyprogesterone Acetate; Prospective Studies; Weight Gain; Young Adult | 2009 |
Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study.
Topics: Adolescent; Adult; Analysis of Variance; Blood Cell Count; Body Mass Index; Body Weight; C-Reactive Protein; Chi-Square Distribution; Cholesterol; Contraceptive Agents, Female; Cytokines; Desogestrel; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant, Newborn; Lactation; Medroxyprogesterone Acetate; Patient Selection; Pilot Projects; Statistics, Nonparametric; Waist Circumference | 2009 |
HRT does not improve urinary albumin excretion in postmenopausal diabetic women.
Topics: Albuminuria; Blood Glucose; Blood Pressure; Body Mass Index; Body Weight; Creatinine; Diabetes Mellitus; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Glycated Hemoglobin; Humans; Lipids; Medroxyprogesterone Acetate; Placebos; Postmenopause | 2003 |
Effect of prolonged use of injectable hormonal contraceptives on blood pressure and body weight.
Topics: Adult; Blood Pressure; Body Weight; Contraceptive Agents, Female; Female; Humans; Injections; Medroxyprogesterone Acetate; Weight Gain | 2004 |
Contraceptive efficacy and safety of DMPA-SC.
Topics: Adult; Amenorrhea; Asia; Blood Pressure; Body Mass Index; Body Weight; Contraceptive Agents, Female; Europe; Female; Humans; Injections, Subcutaneous; Medroxyprogesterone Acetate; Patient Satisfaction; Pregnancy; United States; Uterine Hemorrhage | 2004 |
Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men.
Topics: Aged; Aged, 80 and over; Blood Glucose; Body Weight; Double-Blind Method; Estradiol; Female; Gonadal Steroid Hormones; Human Growth Hormone; Humans; Insulin; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor Binding Protein 4; Insulin-Like Growth Factor Binding Protein 5; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Male; Medroxyprogesterone Acetate; Osteocalcin; Testosterone | 2006 |
Role of ovarian hormones in the regulation of protein metabolism in women: effects of menopausal status and hormone replacement therapy.
Topics: Body Composition; Body Weight; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Gonadal Steroid Hormones; Humans; Keto Acids; Leucine; Medroxyprogesterone Acetate; Metabolism; Middle Aged; Phenylalanine; Postmenopause; Premenopause; Proteins; Serum Albumin | 2006 |
Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation.
Topics: Adult; Body Weight; Bone and Bones; Bone Density; Cohort Studies; Contraceptive Agents, Female; Female; Humans; Lipids; Medroxyprogesterone Acetate; Osteocalcin; Prospective Studies | 2006 |
Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist.
Topics: Administration, Topical; Adolescent; Adult; Body Weight; Contraceptive Agents, Male; Drug Administration Routes; Drug Combinations; Gels; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Injections, Subcutaneous; Insulin; Lipids; Male; Medroxyprogesterone Acetate; Middle Aged; Proteins; Sex Hormone-Binding Globulin; Sperm Count; Spermatogenesis; Testosterone; Treatment Outcome | 2006 |
Comparison of two forms of continuous combined hormone replacement therapy with respect to metabolic effects.
Topics: Adult; Body Weight; Cholesterol; Contraceptive Agents, Female; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Lipoproteins; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies; Triglycerides | 2007 |
Effects of postmenopausal hormone replacement therapy on body fat composition.
Topics: Abdominal Fat; Administration, Cutaneous; Administration, Oral; Adult; Body Fat Distribution; Body Weight; Cardiovascular Diseases; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Risk Factors; Waist-Hip Ratio | 2007 |
Effects of hormonal contraceptives on milk volume and infant growth. WHO Special Programme of Research, Development and Research Training in Human Reproduction Task force on oral contraceptives.
Topics: Adult; Body Height; Body Weight; Breast Feeding; Child Development; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Hungary; Infant; Infant, Newborn; Lactation; Levonorgestrel; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Norgestrel; Pregnancy; Thailand | 1984 |
Hormone therapy in advanced breast cancer: high dose medroxyprogesterone acetate (MAP) vs tamoxifen (TMX). Preliminary results.
Topics: Administration, Oral; Aged; Body Weight; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation; Tamoxifen | 1980 |
WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
Topics: Amenorrhea; Body Weight; Clinical Trials as Topic; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; World Health Organization | 1982 |
Oral 1,25-dihydroxyvitamin D administration in osteoporotic women: effects of estrogen therapy.
Topics: Absorptiometry, Photon; Administration, Oral; Aged; Body Height; Body Weight; Bone Density; Bone Development; Bone Resorption; Calcitriol; Cross-Sectional Studies; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Femur Neck; Humans; Lumbar Vertebrae; Medroxyprogesterone Acetate; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus | 1995 |
A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given monthly by intramuscular injection to Chinese women. I. Contraceptive efficacy and sid effects.
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Body Weight; China; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone Acetate; Menstrual Cycle; Menstruation Disturbances; Norethindrone; Patient Dropouts | 1995 |
Trabecular bone in long-term depot-medroxyprogesterone acetate users.
Topics: Adolescent; Adult; Age Factors; Body Mass Index; Body Weight; Bone Density; Cross-Sectional Studies; Female; Humans; Medroxyprogesterone Acetate; Middle Aged | 1994 |
Progestogen-only contraceptives during lactation: I. Infant growth. World Health Organization Task force for Epidemiological Research on Reproductive Health; Special Programme of Research, Development and Research Training in Human Reproduction.
Topics: Adolescent; Adult; Anthropometry; Body Weight; Child Development; Chile; Contraceptive Agents, Female; Drug Implants; Egypt; Female; Humans; Hungary; Infant; Kenya; Lactation; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Progestins; Prospective Studies; Thailand | 1994 |
The effects of estradiol valerate plus medroxyprogesterone acetate and conjugated estrogens plus medrogestone on climacteric symptoms and metabolic variables in perimenopausal women.
Topics: Adult; Age Factors; Body Weight; Climacteric; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hemostasis; Humans; Lipid Metabolism; Medrogestone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Postmenopause; Premenopause; Progesterone Congeners | 1996 |
Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study.
Topics: Analysis of Variance; Appetite; Body Weight; Carcinoma, Non-Small-Cell Lung; Digestive System Neoplasms; Double-Blind Method; Female; Humans; Lung Neoplasms; Male; Medroxyprogesterone Acetate; Neoplasm Staging; Neoplasms; Progesterone Congeners; Quality of Life; Treatment Outcome | 1996 |
Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception.
Topics: Adolescent; Adult; Amenorrhea; Body Weight; Breast Feeding; China; Contraception; Contraceptive Agents, Female; Counseling; Female; Humans; Medroxyprogesterone Acetate; Menstruation Disturbances; Patient Compliance; Patient Dropouts; Patient Selection; Pregnancy; Progesterone Congeners; Time Factors | 1996 |
Comparative phase III clinical trial of two injectable contraceptive preparations, depot-medroxyprogesterone acetate and Cyclofem, in Vietnamese women.
Topics: Adult; Blood Pressure; Body Weight; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Life Tables; Longitudinal Studies; Medroxyprogesterone Acetate; Menstruation Disturbances; Multicenter Studies as Topic; Patient Dropouts; Patient Selection; Treatment Refusal; Uterine Hemorrhage; Vietnam | 1996 |
Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen-Progestin Interventions Study Investigators.
Topics: Animals; Body Constitution; Body Weight; Chick Embryo; Estrogen Replacement Therapy; Estrogens; Exercise; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Placebos; Postmenopause; Progesterone; Regression Analysis; Smoking | 1997 |
Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium.
Topics: Adult; Antithrombin III; Biopsy; Blood Pressure; Body Weight; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Double-Blind Method; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipoproteins; Medroxyprogesterone Acetate; Middle Aged; Premenopause; Prospective Studies; Triglycerides | 1998 |
Compliance with depot medroxyprogesterone acetate: a randomized, controlled trial of intensive reminders.
Topics: Adult; Body Weight; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Therapy, Computer-Assisted; Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Patient Compliance; Patient Dropouts; Patient Satisfaction; Uterine Hemorrhage | 1998 |
[Study on CAF + medroxyprogesterone acetate (MPA) therapy for advanced or recurrent breast cancer--comparison between MPA 600 mg and 1,200 mg. Kyushu CAFT Therapy Study Group (Third Study)].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Survival Rate | 1999 |
Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): effects of body weight and injection sites on pharmacokinetics.
Topics: Adult; Arm; Body Mass Index; Body Weight; Contraceptive Agents, Female; Estradiol; Female; Hip; Humans; Injections, Intramuscular; Kinetics; Medroxyprogesterone Acetate; Thigh | 1999 |
Reproductive hormones and eating behavior in young women.
Topics: Adult; Body Weight; Cacao; Contraceptive Agents, Female; Energy Intake; Feeding Behavior; Female; Follicular Phase; Humans; Luteal Phase; Medroxyprogesterone Acetate | 2000 |
A multicentered clinical trial of the long-acting injectable contraceptive Depo Provera in Chinese women.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; China; Contraceptive Agents, Female; Female; Humans; Lactation; Medroxyprogesterone Acetate; Menstruation Disturbances; Pregnancy; Vaginal Smears | 2000 |
Short-term effects of a progestational contraceptive drug on food intake, resting energy expenditure, and body weight in young women.
Topics: Adult; Basal Metabolism; Body Weight; Contraceptive Agents, Female; Eating; Female; Follicular Phase; Humans; Luteal Phase; Medroxyprogesterone Acetate; Menstrual Cycle; Single-Blind Method | 2001 |
Bleeding patterns of women using Lunelle monthly contraceptive injections (medroxyprogesterone acetate and estradiol cypionate injectable suspension) compared with those of women using Ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol triphasic) or other
Topics: Adolescent; Adult; Amenorrhea; Body Weight; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Mestranol; Middle Aged; Norethindrone; Patient Compliance; Uterine Hemorrhage | 2000 |
Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
Topics: Body Weight; Bone Density; Bone Remodeling; Calcium; Dose-Response Relationship, Drug; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Osteoporosis; Postmenopause | 2001 |
Effects of different hormone replacement regimens on postmenopausal women with abnormal lipid levels. Menopause Study Group.
Topics: Blood Pressure; Body Weight; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipids; Lipoproteins, HDL; Lipoproteins, HDL2; Medroxyprogesterone Acetate; Placebos; Postmenopause; Prospective Studies; Triglycerides | 1998 |
The impact of different doses of medroxyprogesterone acetate on mood symptoms in sequential hormonal therapy.
Topics: Affect; Blood Pressure; Body Weight; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Humans; Medroxyprogesterone Acetate; Middle Aged; Periodicity; Postmenopause; Premenstrual Syndrome | 2002 |
Oestrogen and cyclical progestogen in postmenopausal hormone replacement therapy.
Topics: Adult; Aged; Blood Pressure; Body Weight; Delayed-Action Preparations; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipids; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Menstruation; Middle Aged; Prospective Studies | 1992 |
Transdermal estradiol with oral progestin: biological and clinical effects in younger and older postmenopausal women.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Aging; Analysis of Variance; Body Mass Index; Body Weight; Delayed-Action Preparations; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Menstruation; Middle Aged; Placebos; Vagina | 1991 |
Clinical evaluation of two monthly injectable contraceptives and their effects on some metabolic parameters.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Blood Proteins; Body Weight; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Lipids; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Norethindrone | 1989 |
A multicentred phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection: I. Contraceptive efficacy and side effects. World Health Organization. Task Force on Long-Acting Systemic Agents for Ferti
Topics: Adult; Amenorrhea; Blood Pressure; Body Weight; Clinical Trials as Topic; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Patient Compliance; Pregnancy; Random Allocation | 1988 |
Cardiovascular side effects of diethylstilbestrol, cyproterone acetate, medroxyprogesterone acetate and estramustine phosphate used for the treatment of advanced prostatic cancer: results from European Organization for Research on Treatment of Cancer tria
Topics: Aged; Body Weight; Cardiovascular Diseases; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Europe; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Nitrogen Mustard Compounds; Prostatic Neoplasms; Random Allocation; Time Factors | 1986 |
A multicentred phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg: 1. Contraceptive efficacy and side effects. World Health Organization Task Force on Long-Acting Systemic Agents for
Topics: Adult; Amenorrhea; Blood Pressure; Body Weight; Clinical Trials as Topic; Contraceptive Agents, Female; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy; Random Allocation | 1986 |
76 other study(ies) available for medroxyprogesterone acetate and Body Weight
| Article | Year |
|---|---|
Changes in body weight and blood pressure among women using Depo-Provera injection in Northwest Ethiopia.
Topics: Adult; Blood Pressure; Body Mass Index; Body Weight; Bone Density; Contraceptive Agents, Female; Cross-Sectional Studies; Female; Humans; Injections; Medroxyprogesterone Acetate; Menstruation; Weight Gain; Young Adult | 2019 |
Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
Topics: Abortion, Induced; Adolescent; Adult; Body Weight; Choice Behavior; Contraception; Contraceptive Agents, Female; Decision Making; Desogestrel; Drug Implants; Educational Status; Female; Humans; Intimate Partner Violence; Intrauterine Devices, Medicated; Levonorgestrel; Logistic Models; Medroxyprogesterone Acetate; Middle Aged; Multivariate Analysis; Pregnancy; Pregnancy, Unplanned; Prospective Studies; Racial Groups; Stress, Psychological; Young Adult | 2015 |
HelpDesk answers: do hormonal contraceptives lead to weight gain?
Topics: Adipose Tissue; Body Weight; Contraceptive Agents, Female; Female; Humans; Medroxyprogesterone Acetate; Weight Gain | 2015 |
Eating disorders, menstrual dysfunction, weight change and DMPA use predict bone density change in college-aged women.
Topics: Adolescent; Body Weight; Bone Density; Demography; Feeding and Eating Disorders; Humans; Least-Squares Analysis; Medroxyprogesterone Acetate; Menstruation; Multivariate Analysis; Physical Fitness; Time Factors | 2016 |
The impact of short-term depot-medroxyprogesterone acetate treatment on resting metabolic rate.
Topics: Adolescent; Adult; Basal Metabolism; Body Composition; Body Mass Index; Body Temperature; Body Weight; Calorimetry, Indirect; Cohort Studies; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Injections, Intramuscular; Luteal Phase; Medroxyprogesterone Acetate; Prospective Studies; Thermogenesis | 2016 |
[Variation of weigth among users of the contraceptive with depot-medroxyprogesterone acetate according to body mass index in a six-year follow-up].
Topics: Adult; Body Mass Index; Body Weight; Contraceptive Agents, Female; Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Retrospective Studies; Time Factors | 2009 |
Prospective study of weight change in new adolescent users of DMPA, NET-EN, COCs, nonusers and discontinuers of hormonal contraception.
Topics: Adolescent; Body Mass Index; Body Weight; Contraception Behavior; Contraceptives, Oral, Combined; Female; Humans; Longitudinal Studies; Medroxyprogesterone Acetate; Norethindrone; Prospective Studies; Weight Gain; Withholding Treatment; Young Adult | 2010 |
Variations in body mass index of users of depot-medroxyprogesterone acetate as a contraceptive.
Topics: Adult; Analysis of Variance; Body Mass Index; Body Weight; Cohort Studies; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Medroxyprogesterone Acetate; Obesity; Overweight; Retrospective Studies; Weight Gain | 2010 |
Effects of long-term treatment with 17 beta-estradiol and medroxyprogesterone acetate on water maze performance in middle aged female rats.
Topics: Aging; Animals; Body Weight; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Hormones; Maze Learning; Medroxyprogesterone Acetate; Models, Animal; Neuropsychological Tests; Organ Size; Ovariectomy; Periodicity; Progesterone; Random Allocation; Rats; Rats, Long-Evans; Time Factors; Uterus | 2010 |
Relationship between weight and bone mineral density in adolescents on hormonal contraception.
Topics: Adolescent; Body Weight; Bone Density; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Weight Gain | 2011 |
Novel C617Y mutation in the 7th transmembrane segment of luteinizing hormone/choriogonadotropin receptor in a Japanese boy with peripheral precocious puberty.
Topics: Animals; Body Height; Body Weight; Child; Chlorocebus aethiops; Chorionic Gonadotropin; COS Cells; Cyclic AMP; Gene Expression; Gonadotropin-Releasing Hormone; Humans; Hypothalamo-Hypophyseal System; Japan; Male; Medroxyprogesterone Acetate; Mutation, Missense; Penis; Polymerase Chain Reaction; Puberty, Precocious; Receptors, LH; Sequence Analysis, DNA; Steroid 21-Hydroxylase; Testis; Testosterone | 2010 |
Is poor nutrition masking the effects of depomedroxyprogesterone acetate on bones in adolescent users?
Topics: Absorptiometry, Photon; Adolescent; Body Weight; Bone Density; Confidence Intervals; Contraceptive Agents, Female; Cross-Sectional Studies; Female; Femur Neck; Humans; Logistic Models; Lumbar Vertebrae; Malnutrition; Medroxyprogesterone Acetate; Multivariate Analysis; Nutritional Status; Odds Ratio; Osteoporosis; Risk Factors; Time Factors; Young Adult | 2010 |
Early weight gain related to later weight gain in adolescents on depot medroxyprogesterone acetate.
Topics: Adolescent; Analysis of Variance; Anthropometry; Body Mass Index; Body Weight; Cohort Studies; Contraceptive Agents, Female; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Risk Factors; Time Factors; Weight Gain | 2011 |
Treatment of cancer cachexia in mice by combination of dsRNA-dependent protein kinase inhibitor and medroxyprogesterone acetate.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blood Glucose; Body Weight; Cachexia; Cytokines; Disease Models, Animal; eIF-2 Kinase; Humans; Male; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Muscle, Skeletal; Neoplasms; Protein Kinase Inhibitors; Tumor Burden | 2012 |
Validity of perceived weight gain in women using long-acting reversible contraception and depot medroxyprogesterone acetate.
Topics: Adult; Body Weight; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Medroxyprogesterone Acetate; Self Concept; Weight Gain | 2013 |
Plasma lipid changes and medroxyprogesterone acetate.
Topics: Biology; Body Weight; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Family Planning Services; Lipids; Medroxyprogesterone Acetate; Metabolism; Physiology; Reproductive Control Agents; Steroids | 1983 |
Depo-provera: clinical evaluation.
Topics: Asia; Body Weight; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Developing Countries; Disease; Endometrium; Evaluation Studies as Topic; Family Planning Services; Human Experimentation; India; Injections; Medroxyprogesterone Acetate; Menstruation Disturbances; Patient Acceptance of Health Care; Research | 1981 |
Exposure to DMPA in pregnancy may cause low birth weight.
Topics: Asia; Asia, Southeastern; Biology; Birth Weight; Body Weight; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Demography; Developing Countries; Family Planning Services; Fertility; Infant Mortality; Infant, Low Birth Weight; Injections; International Agencies; Longevity; Medroxyprogesterone Acetate; Mortality; Organizations; Physiology; Population; Population Dynamics; Pregnancy; Pregnancy Outcome; Reproduction; Risk Factors; Sexual Behavior; Survival Rate; Thailand; United Nations; World Health Organization | 1992 |
Ask the experts: progestin-only contraceptives.
Topics: Age Factors; Amenorrhea; Americas; Appetite; Biology; Body Weight; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Data Collection; Demography; Developed Countries; Disease; Drug Interactions; Family Planning Services; Hypersensitivity; Interviews as Topic; Medroxyprogesterone Acetate; Menstruation Disturbances; North America; Pharmaceutical Preparations; Physiology; Population; Population Characteristics; Progesterone Congeners; Research; Signs and Symptoms; Therapeutics; United States | 1993 |
Pretreatment counseling keeps patients on Depo.
Topics: Ambulatory Care Facilities; Biology; Body Weight; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Counseling; Disease; Economics; Family Planning Services; Health Planning; Health Services Needs and Demand; Hemorrhage; Injections; Medroxyprogesterone Acetate; Metrorrhagia; Organization and Administration; Physiology; Signs and Symptoms | 1997 |
[Clinical investigation of medroxyprogesterone acetate and estradiol cypionate in contraceptive injection administered monthly].
Topics: Biology; Body Weight; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Endocrine System; Endometrium; Estradiol; Estrogens; Family Planning Services; Genitalia; Genitalia, Female; Hormones; Hypertension; Injections; Medroxyprogesterone Acetate; Physiology; Research; Urogenital System; Uterus; Vascular Diseases | 1975 |
Serum vitamin A, carotene and cholesterol levels in Nigerian women using various types of contraceptives.
Topics: Africa; Africa South of the Sahara; Africa, Western; Age Factors; Biology; Body Weight; Clinical Laboratory Techniques; Contraception; Contraceptive Agents, Female; Contraceptives, Oral; Developing Countries; Educational Status; Ethinyl Estradiol; Family Planning Services; Health; Hematocrit; Injections; Intrauterine Devices; Intrauterine Devices, Copper; Lipids; Medroxyprogesterone Acetate; Mestranol; Nigeria; Norethynodrel; Nutritional Physiological Phenomena; Parity; Physiology; Population Characteristics; Vitamin A; Vitamins | 1982 |
FDA advisory panel recommends approval for Depo-Provera.
Topics: Americas; Biology; Birth Weight; Body Weight; Consumer Product Safety; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Disease; Family Planning Services; Infant, Low Birth Weight; Injections; Legislation as Topic; Medroxyprogesterone Acetate; Neoplasms; North America; Physiology; United States | 1992 |
Teens and Depo-Provera: a good match?
Topics: Adolescent; Age Factors; Ambulatory Care Facilities; Americas; Appetite; Behavior; Biology; Body Weight; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Counseling; Demography; Developed Countries; Diet; Disease; Family Planning Services; Health; Health Planning; Medroxyprogesterone Acetate; North America; Nutritional Physiological Phenomena; Organization and Administration; Physiology; Population; Population Characteristics; Risk-Taking; Sexual Behavior; Signs and Symptoms; United States | 1995 |
[Effect of MPA and MPA + TU on the rat spermatogenesis and sexual hormones].
Topics: Animals; Body Weight; Drug Interactions; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Luteinizing Hormone; Male; Medroxyprogesterone Acetate; Organ Size; Rats; Rats, Sprague-Dawley; Spermatogenesis; Testosterone | 2002 |
[Effect of 6alpha-methyl-17alpha-hydroxyprogesterone acetate with and without ACTH on the weight of the adrenal glands of intact and ovariectomzed rats].
Topics: Acetates; Adrenal Glands; Adrenocorticotropic Hormone; Animals; Body Weight; Castration; Humans; Hydroxyprogesterones; Male; Medroxyprogesterone Acetate; Orchiectomy; Progesterone; Rats | 1960 |
Effects of tibolone and conjugated equine estrogens with or without medroxyprogesterone acetate on body composition and fasting carbohydrate measures in surgically postmenopausal monkeys.
Topics: Animals; Arteriosclerosis; Blood Glucose; Body Composition; Body Weight; C-Peptide; Carbohydrates; Dietary Fats; Energy Intake; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Fasting; Female; Fructosamine; Insulin; Insulin Resistance; Macaca fascicularis; Medroxyprogesterone Acetate; Norpregnenes; Ovariectomy; Postmenopause | 2003 |
Norgestimate and medroxyprogesterone acetate do not attenuate the atheroprotective effects of 17beta-estradiol in ovariectomized, apolipoprotein E-deficient mice.
Topics: Adipose Tissue; Animals; Apolipoproteins E; Arteriosclerosis; Blood Glucose; Body Weight; Dose-Response Relationship, Drug; Estradiol; Female; Insulin; Lipids; Lipoproteins; Medroxyprogesterone Acetate; Mice; Mice, Knockout; Norgestrel; Organ Size; Ovariectomy; Random Allocation; Sinus of Valsalva | 2004 |
Weight, fat mass, and central distribution of fat increase when women use depot-medroxyprogesterone acetate for contraception.
Topics: Absorptiometry, Photon; Adipose Tissue; Adolescent; Adult; Body Composition; Body Fat Distribution; Body Weight; Contraceptive Agents, Female; Female; Humans; Longitudinal Studies; Medroxyprogesterone Acetate; Prospective Studies | 2005 |
A comparison of two progestins on myocardial ischemia-reperfusion injury in ovariectomized monkeys receiving estrogen therapy.
Topics: Animals; Biomarkers; Blood Flow Velocity; Blood Pressure; Body Weight; Contraceptive Agents, Female; Coronary Circulation; Disease Models, Animal; Drug Interactions; Estrogens; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Haplorhini; Heart Rate; Lipids; Medroxyprogesterone Acetate; Myocardial Reperfusion Injury; Neovascularization, Physiologic; Norethindrone; Norethindrone Acetate; Ovariectomy; Peroxidase; Progestins; Research Design; Stroke Volume; Vascular Resistance | 2005 |
Effects of estrogen and progestin on hypothalamic blood flow autoregulation.
Topics: Animals; Blood Pressure; Blood Volume; Body Weight; Carbon Dioxide; Cerebrovascular Circulation; Contraceptive Agents, Female; Estradiol; Female; Homeostasis; Hypothalamus; Medroxyprogesterone Acetate; Ovariectomy; Oxygen; Rats; Rats, Sprague-Dawley | 2005 |
Weight changes in clients on hormonal contraceptives in Zaria, Nigeria.
Topics: Adult; Body Weight; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Female; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Retrospective Studies; Weight Gain; Weight Loss | 2005 |
Addition of medroxyprogesterone acetate to conjugated equine estrogens results in insulin resistance in adipose tissue.
Topics: Adipocytes; Adipose Tissue; Animals; Body Composition; Body Weight; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Insulin Resistance; Macaca fascicularis; Medroxyprogesterone Acetate | 2007 |
Long-term contraception with Depo-Provera: a clinical evaluation.
Topics: Adolescent; Adult; Body Weight; Delayed-Action Preparations; Drug Evaluation; Female; Follow-Up Studies; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation | 1980 |
Some effects of depo-medroxyprogesterone acetate (DMPA): observations in the nursing infant and in the long-term user.
Topics: Abnormalities, Drug-Induced; Birth Weight; Body Weight; Child, Preschool; Delayed-Action Preparations; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Infections; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Postpartum Period; Pregnancy; Prenatal Exposure Delayed Effects | 1982 |
Effects of hexestrol, medroxyprogesterone acetate and chlormadinone acetate on 7, 12-dimethylbenz [a] anthracene-induced rat mammary cancer in relation to estrogen receptor.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Body Weight; Chlormadinone Acetate; Delayed-Action Preparations; Female; Hexestrol; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Rats; Rats, Inbred Strains; Receptors, Estrogen | 1981 |
Transfer of contraceptive steroids in milk of women using long-acting gestagens.
Topics: Adult; Body Weight; Contraceptive Agents, Female; Contraceptives, Oral; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Norethindrone | 1982 |
Abnormalities of fuel metabolism in the polycystic ovary syndrome.
Topics: Adult; Blood Glucose; Body Weight; Cholesterol; Cholesterol, HDL; Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Lipids; Lipoproteins, HDL; Medroxyprogesterone; Medroxyprogesterone Acetate; Polycystic Ovary Syndrome; Testosterone; Triglycerides | 1982 |
Alterations in blood lipids and side effects induced by depo-provera in Nigerian women.
Topics: Adult; Body Weight; Cholesterol; Contraceptive Agents, Female; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Nigeria; Phospholipids; Time Factors; Triglycerides | 1983 |
Long-term follow-up of children breast-fed by mothers receiving depot-medroxyprogesterone acetate.
Topics: Adult; Body Height; Body Weight; Child Development; Contraceptive Agents, Female; Female; Follow-Up Studies; Health Status; Humans; Infant; Infant, Newborn; Lactation; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy; Psychomotor Performance | 1984 |
Influence of gonadal hormones on adipose-tissue cellularity in rats.
Topics: Adipose Tissue; Adrenalectomy; Aging; Animals; Body Weight; Castration; Estradiol; Female; Medroxyprogesterone; Medroxyprogesterone Acetate; Organophosphorus Compounds; Ovary; Rats | 1980 |
Progesterone administration and progressive sleep apneas.
Topics: Adult; Aged; Body Weight; Carbon Dioxide; Disorders of Excessive Somnolence; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Pulmonary Ventilation; Sleep Apnea Syndromes | 1981 |
Experimental study on the anabolic and androgenic/antiandrogenic activity of different dose levels of medroxyprogesterone acetate (MAP) in rats.
Topics: Administration, Oral; Animals; Body Weight; Castration; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Organ Size; Prostate; Rats; Seminal Vesicles | 1981 |
Effects of hormone replacement therapy on weight, body composition, fat distribution, and food intake in early postmenopausal women: a prospective study.
Topics: Adult; Anthropometry; Body Composition; Body Constitution; Body Mass Index; Body Weight; Eating; Energy Intake; Estrogen Replacement Therapy; Estrogens; Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone Congeners; Prospective Studies | 1995 |
Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
Topics: Administration, Oral; Adolescent; Adult; Apolipoprotein A-I; Bilirubin; Body Weight; Cholesterol; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Implants; Female; Humans; Injections, Intramuscular; Levonorgestrel; Lipoproteins; Medroxyprogesterone Acetate; Menstrual Cycle; Norethindrone; Progestins; Sex Hormone-Binding Globulin; Time Factors; Triglycerides; United States | 1995 |
The effect of medroxyprogesterone acetate on bone metabolism in the oophorectomized, tamoxifen-treated rat.
Topics: Animals; Body Weight; Bone Remodeling; Calcitriol; Calcium; Drug Interactions; Female; Insulin-Like Growth Factor I; Medroxyprogesterone Acetate; Osteocalcin; Osteoclasts; Ovariectomy; Parathyroid Hormone; Rats; Rats, Sprague-Dawley; Tamoxifen; Tibia | 1995 |
Pharmacological interference with tissue hypercatabolism in tumour-bearing rats.
Topics: Adrenalectomy; Animals; Aspirin; Blood Glucose; Body Weight; Cachexia; Cathepsin D; Cholesterol; Endopeptidases; Hormones; Insulin; Leupeptins; Male; Medroxyprogesterone Acetate; Muscle Proteins; Neoplasm Transplantation; Neoplasms, Experimental; Rats; Rats, Wistar; Triglycerides | 1994 |
[Effect of medroxyprogesterone acetate on antitumor efficacies and side effect of 5-fluorouracil].
Topics: Animals; Body Weight; Bone Marrow; Drug Synergism; Female; Fluorouracil; Lethal Dose 50; Male; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred C3H | 1993 |
Short-term effects of high dose oral medroxyprogesterone acetate on bone density in premenopausal women.
Topics: Administration, Oral; Adult; Body Weight; Bone Density; Dose-Response Relationship, Drug; Estradiol; Female; Femur Neck; Humans; Lumbosacral Region; Medroxyprogesterone Acetate; Middle Aged; Premenopause; Spine; Time Factors | 1996 |
Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery.
Topics: Animals; Body Weight; Carotid Arteries; Carotid Artery Injuries; Catheterization; Estradiol; Female; Male; Medroxyprogesterone Acetate; Orchiectomy; Ovariectomy; Progesterone; Progesterone Congeners; Rats; Rats, Sprague-Dawley; Tunica Intima | 1996 |
Effects of chronic hormone replacement on the renin-angiotensin system in cynomolgus monkeys.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Body Weight; Drug Interactions; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Macaca fascicularis; Medroxyprogesterone Acetate; Peptidyl-Dipeptidase A; Renin; Renin-Angiotensin System | 1997 |
Adolescent satisfaction with postpartum contraception and body weight concerns.
Topics: Adolescent; Adolescent Health Services; Adult; Body Image; Body Weight; Contraceptive Agents, Female; Counseling; Female; Humans; Male; Medroxyprogesterone Acetate; Patient Satisfaction; Postpartum Period; Pregnancy; Pregnancy in Adolescence | 1998 |
[The effect of hormone substitution therapy on body weight].
Topics: Body Mass Index; Body Weight; Dose-Response Relationship, Drug; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Postmenopause | 1998 |
Medroxyprogesterone acetate inhibits interleukin 6 secretion from KPL-4 human breast cancer cells both in vitro and in vivo: a possible mechanism of the anticachectic effect.
Topics: Animals; Antineoplastic Agents, Hormonal; Body Weight; Breast Neoplasms; Cachexia; Female; Humans; Injections, Intramuscular; Interleukin-6; Medroxyprogesterone Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Tumor Cells, Cultured | 1999 |
Weight variation in users of the once-a-month injectable contraceptive Cyclofem.
Topics: Adult; Body Weight; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Menstrual Cycle; Weight Gain | 1998 |
The effects of feeding an Asian or Western diet on sperm numbers, sperm quality and serum hormone levels in cynomolgus monkeys (Macaca fascicularis) injected with testosterone enanthate (TE) plus depot medroxyprogesterone acetate (DMPA).
Topics: Animal Feed; Animals; Asia; Body Weight; Contraceptive Agents, Male; Feeding Behavior; Follicle Stimulating Hormone; Luteinizing Hormone; Macaca fascicularis; Male; Medroxyprogesterone Acetate; Sperm Count; Spermatozoa; Testosterone | 1999 |
Evaluation of the body composition and fat distribution in long-term users of hormone replacement therapy.
Topics: Adipose Tissue; Administration, Cutaneous; Aged; Aging; Body Composition; Body Constitution; Body Height; Body Mass Index; Body Weight; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Parity | 1999 |
Weight change in adolescents who used hormonal contraception.
Topics: Adolescent; Adult; Body Mass Index; Body Weight; Contraceptives, Oral; Female; Humans; Medroxyprogesterone Acetate; Retrospective Studies; Time Factors | 1999 |
Effects of DMPA on weight and blood pressure in long-term acceptors.
Topics: Adult; Blood Pressure; Body Weight; Contraceptive Agents, Female; Drug Implants; Female; Humans; Intrauterine Devices; Medroxyprogesterone Acetate; Middle Aged; Parity; Time Factors | 1999 |
The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy.
Topics: Adult; Biopsy; Body Weight; Cervix Uteri; Contraceptive Agents, Female; Epithelium; Estradiol; Female; Humans; Image Processing, Computer-Assisted; Injections, Intramuscular; Langerhans Cells; Medroxyprogesterone Acetate; Menstrual Cycle; Photography; Progesterone; Regression Analysis; Statistics, Nonparametric; Vagina | 1999 |
Reproductive performance of ewe lambs from ewes from different selection practices with or without induced estrus.
Topics: Administration, Intravaginal; Animals; Body Weight; Breeding; Chorionic Gonadotropin; Estrus; Female; Male; Medroxyprogesterone Acetate; Pessaries; Pregnancy; Reproduction; Seasons; Selection, Genetic; Sheep; Weaning | 2001 |
Forearm bone density in long-term users of oral combined contraceptives and depot medroxyprogesterone acetate.
Topics: Absorptiometry, Photon; Adult; Body Mass Index; Body Weight; Bone Density; Contraceptives, Oral, Combined; Cross-Sectional Studies; Drug Implants; Female; Forearm; Humans; Medroxyprogesterone Acetate; Occupations; Pregnancy; Regression Analysis | 2001 |
Estrogen increases endothelial nitric oxide synthase via estrogen receptors in rat cerebral blood vessels: effect preserved after concurrent treatment with medroxyprogesterone acetate or progesterone.
Topics: Animals; Blood Vessels; Body Weight; Brain; Dose-Response Relationship, Drug; Drug Implants; Enzyme Activation; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Fulvestrant; In Vitro Techniques; Medroxyprogesterone Acetate; Models, Animal; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Organ Size; Ovariectomy; Progesterone; Rats; Rats, Inbred F344; Receptors, Estrogen; Tamoxifen; Uterus | 2002 |
The long-term growth and development of children exposed to Depo-Provera during pregnancy or lactation.
Topics: Adolescent; Body Height; Body Weight; Child; Child, Preschool; Cohort Studies; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Growth; Humans; Infant; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Pregnancy; Prenatal Exposure Delayed Effects; Puberty; Regression Analysis | 1992 |
Modulatory influence of injectable contraceptive steroid medroxyprogesterone acetate on methylcholanthrene-induced carcinogenesis in the uterine cervix of mouse.
Topics: Administration, Intravaginal; Animals; Body Weight; Contraceptive Agents, Female; Cytochrome P-450 Enzyme System; Cytochromes b5; Drug Interactions; Female; Glutathione Transferase; Liver; Medroxyprogesterone; Medroxyprogesterone Acetate; Methylcholanthrene; Mice; Sulfhydryl Compounds; Uterine Cervical Neoplasms | 1992 |
[Effect of short-term administration of medroxyprogesterone acetate on side reactions of combination chemotherapy with ADR, VDS and CDDP in primary lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Body Weight; Cisplatin; Doxorubicin; Drug Administration Schedule; Humans; Leukocyte Count; Lung Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Nausea; Vindesine; Vomiting | 1991 |
Protective effect of medroxyprogesterone acetate plus testosterone against radiation-induced damage to the reproductive function of male rats and their offspring.
Topics: Animals; Body Weight; Drug Administration Schedule; Epididymis; Fertility; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Organ Size; Radiation Injuries, Experimental; Radiation-Protective Agents; Rats; Rats, Inbred Strains; Sperm Count; Spermatogenesis; Testis; Testosterone | 1991 |
Transdermal estrogen therapy in menopause. Eighteen months follow-up.
Topics: Administration, Cutaneous; Adult; Blood Pressure; Body Weight; Bone Density; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipids; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged | 1991 |
[Treatment of sleep apnea syndromes].
Topics: Acetazolamide; Body Weight; Humans; Hyperbaric Oxygenation; Medroxyprogesterone; Medroxyprogesterone Acetate; Oxygen Inhalation Therapy; Posture; Sleep; Sleep Apnea Syndromes; Tracheotomy | 1990 |
The effect of age, weight-related parameters and hormonal contraceptives on andrological assays.
Topics: Age Factors; Body Weight; Contraceptives, Oral, Hormonal; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Reference Values; Sex Hormone-Binding Globulin; Testosterone | 1986 |
Effect of medroxyprogesterone acetate on hepatic and placental drug metabolism in rats.
Topics: Animals; Body Weight; Female; Liver; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Placenta; Pregnancy; Rats; Rats, Inbred Strains | 1986 |
Effect of anabolic steroids, alone or in combination with antibiotics, on bull performance, carcass traits and meat quality characteristics.
Topics: Anabolic Agents; Androgens; Animal Feed; Animals; Body Weight; Cattle; Eating; Estrogens; Lasalocid; Male; Meat; Medroxyprogesterone; Medroxyprogesterone Acetate; Virginiamycin | 1988 |
Physical, metabolic, and hormonal effects on men of long-term therapy with medroxyprogesterone acetate.
Topics: Adult; Blood Pressure; Body Weight; Follicle Stimulating Hormone; Gallbladder Diseases; Glucose Tolerance Test; Hematologic Tests; Humans; Injections, Intramuscular; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Paraphilic Disorders; Penis; Semen; Sperm Count; Sperm Motility; Testis; Testosterone; Time Factors | 1985 |
Inhibition by medroxyprogesterone acetate of precancerous mammary hyperplastic alveolar nodule formation in mice.
Topics: Animals; Antineoplastic Agents; Body Weight; Estrus; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Inbred Strains; Organ Size; Precancerous Conditions; Pregnancy; Prolactin | 1985 |
[Therapeutic effects of medroxyprogesterone acetate in recurrent or advanced breast cancer].
Topics: Administration, Oral; Adult; Aged; Body Weight; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Recurrence, Local | 1985 |
[Depot medroxyprogesterone acetate: clinical and metabolic effects (lipids, glucose, hemostasis)].
Topics: Adolescent; Adult; Animals; Blood Glucose; Body Weight; Contraceptive Agents, Female; Delayed-Action Preparations; Dogs; Female; Hemostasis; Humans; Hypertension; Injections, Intramuscular; Lipids; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Middle Aged; Retrospective Studies | 1985 |